Aurinia Pharmaceuticals Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 77.7M | 77.1M | 73.5M | 70.0M | 62.5M | 59.9M | 67.8M | 57.2M |
| Cost of Goods Sold | 6.5M | 8.5M | 8.5M | 7.1M | 8.6M | 5.6M | 6.0M | 8.9M |
| Gross Profit | 71.2M | 68.6M | 65.0M | 62.9M | 53.9M | 54.3M | 61.7M | 48.3M |
| R&D Expenses | 7.5M | 10.9M | 8.4M | 7.4M | 5.7M | 8.1M | 3.0M | 4.1M |
| Operating Expenses | 29.8M | 35.4M | 35.2M | 42.8M | 32.0M | 56.0M | 50.0M | 49.8M |
| Operating Income | 41.4M | 33.2M | 29.7M | 20.1M | 21.8M | -1.7M | 11.7M | -1.5M |
| Other Income / Gains | 2.5M | 2.5M | 2.2M | 2.1M | 2.5M | 2.8M | 3.1M | 3.0M |
| Net Income | 34.4M | 210.8M | 31.6M | 21.5M | 23.3M | 1.4M | 14.3M | 722K |
| EPS (Diluted) | 0.26 | 1.58 | 0.24 | 0.16 | 0.16 | 0.01 | 0.10 | 0.01 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.916 | 0.89 | 0.884 | 0.898 | 0.863 | 0.907 | 0.911 | 0.844 |
| General And Administrative Expenses | 21.7M | 28.5M | 25.6M | 25.2M | 19.4M | 31.2M | 37.9M | 40.7M |
| Selling And Marketing Expenses | 327K | 785K | 605K | 848K | 970K | 14.1M | 4.5M | 4.2M |
| Selling General And Administrative Expenses | 22.0M | 29.3M | 26.2M | 26.0M | 20.3M | 45.3M | 42.4M | 44.9M |
| Other Expenses | 279K | -4.7M | 602K | 9.4M | 6.0M | 2.6M | 4.6M | 782K |
| Cost And Expenses | 36.3M | 43.9M | 43.7M | 49.9M | 40.6M | 61.5M | 56.0M | 58.7M |
| Interest Income | 3.5M | 4.6M | 2.2M | 3.2M | 3.6M | 4.0M | 4.3M | 4.2M |
| Interest Expense | 1.0M | 6.5M | 0 | 1.1M | 1.1M | 1.1M | 1.2M | 1.2M |
| Depreciation And Amortization | 4.8M | 4.9M | 4.9M | 4.9M | 4.9M | 4.9M | 4.9M | 4.8M |
| Ebitda | 49.8M | 47.1M | 36.8M | 28.1M | 30.3M | 7.2M | 20.9M | 7.5M |
| Ebitdaratio | 0.64 | 0.61 | 0.501 | 0.402 | 0.485 | 0.12 | 0.309 | 0.131 |
| Operating Income Ratio | 0.533 | 0.431 | 0.405 | 0.287 | 0.35 | -0.028 | 0.173 | -0.026 |
| Income Before Tax | 43.9M | 35.7M | 32.0M | 22.2M | 24.3M | 1.2M | 14.8M | 1.5M |
| Income Before Tax Ratio | 0.565 | 0.463 | 0.435 | 0.316 | 0.39 | 0.02 | 0.218 | 0.026 |
| Income Tax Expense | 9.6M | -175.1M | 411K | 643K | 1.0M | -256K | 457K | 756K |
| Net Income Ratio | 0.442 | 2.734 | 0.429 | 0.307 | 0.374 | 0.024 | 0.212 | 0.013 |
| Epsdiluted | 0.25 | 1.53 | 0.23 | 0.15 | 0.16 | 0.01 | 0.099 | 0.01 |
| Weighted Average Shs Out | 132.4M | 134.4M | 137.2M | 138.9M | 138.9M | 142.2M | 143.1M | 143.3M |
| Weighted Average Shs Out Dil | 137.6M | 138.7M | 136.0M | 143.2M | 138.9M | 147.7M | 145.7M | 144.1M |